A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis

Phase 2

Completed

• Conditions: Pneumonia; Sepsis

• Registration Number: NCT00042588
• Lead Sponsor: ICOS Corporation

Brief Summary

The objective of this study is to demonstrate the safety and efficacy of IC14 in the treatment of hospitalized patients with community-acquired pneumonia and sepsis.

Detailed Description

Not available

Study Timeline

• Study Start: 2002-05
• Study First Submitted: 2002-08-01
• Study First Submitted QC: 2002-08-02
• Study First Posted: 2002-08-05
• Status Verified: 2004-01
• Last Update Submitted: 2005-06-23
• Last Update Posted: 2005-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Current diagnosis of community-acquired pneumonia.
• Evidence of systemic inflammatory response to infection.

Exclusion Criteria

• Atypical or viral pneumonia based on clinical or epidemiologic suspicion by the investigator.
• Presence of organ failure.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (1)

ICOS Corporation; 🇺🇸 Bothell, Washington, United States